Taken together, these findings suggest that loss of PDE4D7 may represent an early, clonal event in ETS fusion-negative PCa and provides significant evidence that PDE4D7 expression is involved in PCa progression and is inversely associated with progression-free and disease-specific survival after prostate-specific antigen relapse. Here, KLK3 is linked to posterior cortical atrophy.